期刊文献+

2017年北京地区水痘病原学监测结果分析 被引量:6

Analysis on etiological surveillance results of varicella in Beijing, 2017
原文传递
导出
摘要 目的了解北京地区水痘–带状疱疹病毒(VZV)毒株类型及优势流行亚型,为水痘暴发疫情的防治提供依据。方法收集2017年北京地区水痘暴发疫情病例的疱疹液标本。采用实时荧光PCR方法,进行VZV及野毒株和疫苗株鉴定,根据VZV第22个开放阅读框基因片段序列,确定北京地区VZV进化关系。结果 2017年共收集到水痘病例标本316份,VZV病毒核酸阳性271份,阳性率为85.76%,均为野毒株。共获得240份VZV基因片段,其中234株毒株是clade2型,占97.50%,3株clade1型和3株clade4型,分别占1.25%。其中clade2型分布在北京地区16个区(县),clade1型和clade4型分别分布在西城区和大兴区。结论 2017年北京地区水痘病例主要由clade2型VZV引起,同时对新出现的clade1型和clade4型要加强监测。 Objective To understand the types and predominant types of varicella-zoster virus(VZV) in Beijing,2017,and provide evidence for the prevention and control of varicella.Methods The clinical vesicular fluid was collected from the varicella cases detected in outbreak of Beijing in 2017 for the identification of wild strains and vaccine strains of VZV with real-time PCR.The phylogenetic analysis on wild VZV in Beijing was performed based on the sequences of twenty-second open reading frame gene fragment(ORF).Results Among the 316 vesicular fluid specimens from varicella cases,271 were positive for VZV.All of these strains belonged to wild VZV strains.The gene fragments were obtained for 240 of 271 wild strains.They belonged to 3 serotypes,including 234 clade 2 strains(97.50%),3 clade 1 strains(1.25%) and 3 clade 4 strains(1.25%).Clade 2 strains was distributed in all of 16 districts of Beijing,and clade 1 and clade 4 strains were distributed in Xicheng and Daxing districts,respectively.Conclusion The varicella cases were mainly caused by clade 2 VZV in Beijing in2017.It is necessary to strengthen the surveillance for new clade 1 and clade 4 VZV.
作者 李洪权 索罗丹 赵丹 张铁钢 Li Hongquan;Suo Luodan;Zhao Dan;Zhang Tiegang(Beijing Municipal Center for Disease Control and Prevention,Beijing 100013,China)
出处 《疾病监测》 CAS 2019年第6期511-513,共3页 Disease Surveillance
关键词 水痘 水痘-带状疱疹病毒 基因型 Varicella Varicella- zoster virus Genotype
  • 相关文献

参考文献9

二级参考文献90

  • 1程朝霞,向辉,李标.人群水痘—带状疱疹病毒流行率及发病状况分析[J].中国公共卫生管理,2004,20(4):358-359. 被引量:38
  • 2宋小莺,李惠琴,胡时豪.一起幼儿园水痘爆发的调查[J].上海预防医学,1999,11(7):317-317. 被引量:4
  • 3郑官增,朱函平,袁文平.聚合酶链反应检测水痘带状疱疹病毒DNA[J].中国卫生检验杂志,2005,15(11):1388-1388. 被引量:4
  • 4金连梅,冯子健.2005-2006年全国水痘疫情分析[J].疾病监测,2007,22(4):251-252. 被引量:106
  • 5Gershon AA. The current status of live attenuated varicella vaccine. Arch Virol Suppl, 2001, (17) : 1-6.
  • 6Grose C. Varicella zoster virus : Out of Africa and into the research laboratory. Herpes, 2006, 13(2) : 32-36.
  • 7Quinlivan M, Gershon AA, Steinberg S, et al. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus. J Med Virol, 2005, 75 ( 1 ) : 174-180.
  • 8Vazquez M, LaRussa PS, Gershon AA, et al. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med, 2001, 29: 344(13): 955-960.
  • 9Uebe B, Sauerbrei A, Burdach S, et al. Herpes zoster by reactivated vaccine varicella-zoster virus in a healthy child. Eur J Pediatr, 2002, 161(8): 442-444.
  • 10Hambleton S, Steinberg SP, LaRussa PS, et al. Risk of herpes zoster in adults immunized with variceUa vaccine. J Infect Dis, 2008, 197 (Suppl 2): S196-199.

共引文献193

同被引文献44

引证文献6

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部